COMMUNIQUÉS West-GlobeNewswire

Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab
21/09/2026
BOSTON, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day
21/09/2026
The Shared Goals: Navigating Alzheimer’s Agitation survey finds that Alzheimer’s disease agitation is often only recognized after daily life is significantly disrupted Ninety-seven percent of care partners reported that [...]
Seer Announces CFO Transition
21/09/2026
REDWOOD CITY, Calif., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that David Horn, the [...]
Vironexis Announces Complete and Durable Responses in Relapsed/Refractory ALL Patients Treated with VNX-101
21/09/2026
In the ongoing SENTRY-CD19 trial, all three anti-AAV antibody-naïve patients with relapsed/refractory acute lymphoblastic leukemia (ALL) have achieved MRD-negative complete responses following a single administration of [...]
Beacon Therapeutics Reports Positive Topline Data from the Pivotal VISTA Trial of Laru-zova for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
21/09/2026
VISTA met its FDA-endorsed primary endpoint, demonstrating statistically significant low luminance visual acuity (LLVA) responder rates at Month 12 compared to the untreated control group A statistically significant [...]
Dr. Maximilian Doebler appointed Chief Executive Officer of HMNC Brain Health as Company moves into next phase of global growth
21/09/2026
HMNC recently closed a $50 million Series B financing and a European commercialization partnership with MEDICE for its Ketabon program Doebler has helped shape HMNC's development since 2019, most recently as Managing [...]
InflaRx to Host Virtual Capital Markets Day
21/09/2026
Event to be hosted on November 3, 2026 at 8:00 AM EST Featured speakers will include Peter A. Merkel, MD, MPH and Prof. Dr. Jörg Köhl Jena, Germany, Sept. 21, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a [...]
Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
21/09/2026
Decision advances Company’s previously announced capital-efficient development strategy by concentrating resources on FDA-authorized, SKNJCT-005, NDA-enabling, Registrational Phase 2b Study in Gorlin syndrome patients [...]
Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026
21/09/2026
Poster presentations further characterize clinical profile of HLP003 and Phase 3 PARADIGM program evaluating HLP003 as a potential adjunctive treatment for major depressive disorder (“MDD”) NEW YORK and TORONTO, Sept. [...]
HealthLynked Announces Strategic Enterprise Pilot with Palm Beach Accountable Care Organization to Advance AI-Powered Patient Engagement and Value-Based Care
21/09/2026
NAPLES, Fla., Sept. 21, 2026 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK ), a healthcare technology company focused on AI-powered patient engagement and care coordination, today announced a strategic [...]
Change to American Depositary Share Ratio
21/09/2026
SYDNEY, AUSTRALIA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces a [...]
Microdose Tirzepatide: New Study Reports 4.4- to 6.9-Pound Average Weight Loss by Day 59
21/09/2026
Retrospective analysis of 60 adults on compounded tirzepatide, 1–2 mg weekly: 4.4 lb average among 57 at days 14–35, 6.9 lb among 19 at days 36–59; not peer reviewed ALPHARETTA, Ga., Sept. 21, 2026 (GLOBE NEWSWIRE) -- A [...]
Hoag Hospital Irvine Sun Family Campus Now Open, Introducing a New Model for Specialized Care in Orange County
21/09/2026
Six-Building Expansion Brings Specialized Hospital and Outpatient Care Together on One Integrated Campus Dedicated Cancer, Women’s Health, Digestive Health and Surgical Facilities Expand Access to Advanced Care in [...]
NeOnc Charting New Nasal Route to Treating Brain Cancer
21/09/2026
DENVER, Sept. 21, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – NeOnc Technologies Holdings’ (NASDAQ: NTHI) NEO100 deserves attention; not just because its Phase 2a study has suddenly solved brain cancer, but because [...]
KFSH Recognized in Newsweek’s World’s Best Specialized Hospitals 2027
21/09/2026
RIYADH, Saudi Arabia, Sept. 21, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) has reinforced its position as a global healthcare leader, earning prominent placement in Newsweek’s [...]
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
21/09/2026
Investment was led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s Chief Executive Officer and other existing shareholders $4 million registered direct [...]
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
21/09/2026
Dr. Elkeles Brings Deep Experience and Proven Track Record in Shaping Human Capital Strategy to Support Strategic Growth and Operational Execution DELRAY BEACH, Fla., Sept. 21, 2026 (GLOBE NEWSWIRE) -- PetMed Express, [...]
Novo Nordisk A/S - share repurchase programme
21/09/2026
Bagsværd, Denmark, 21 September 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Z Optics Presents Six-Month Clinical Results for the Z+ Virtual Aperture IOL at ESCRS 2026
21/09/2026
Data presented by Dr. Francisco Sánchez León in London show reliably good uncorrected vision at distance, intermediate and near, in daylight and in low light, with no serious adverse events and every patient free of [...]

Pages